Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K.

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers DURHAM, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it has completed a multi-year effort to expand its clinical […]

Continue Reading

LeddarTech Anuncia sua Participação em Conferências do Quarto Trimestre de 2023 com o Investidor

QUEBEC CITY, Canadá, Nov. 01, 2023 (GLOBE NEWSWIRE) — A LeddarTech®, uma empresa de software automotivo que fornece tecnologia patenteada de software de fusão e percepção de sensores de baixo nível para ADAS e AD, anuncia a participação de Frantz Saintellemy, Presidente e CEO, nos seguintes eventos com investidores: 9 de novembro de 2023 – […]

Continue Reading